NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Buy
51
HALO Quote, Financials, Valuation and Earnings
Last price:
$47.17
Seasonality move
:
7.09%
Day range:
$46.88 - $48.21
52-week range:
$33.15 - $65.53
Dividend yield:
0%
P/E ratio:
15.54x
P/S ratio:
6.43x
P/B ratio:
13.19x
Volume:
4.5M
Avg. volume:
2M
1-year change:
29%
Market cap:
$6B
Revenue:
$829.3M
EPS (TTM):
$3.02
Halozyme Therapeutics SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
HALO
Halozyme Therapeutics
|
05/07/2024 | 10-Q | 10-Q filing on 05/07/2024 | View Form |
|
HALO
Halozyme Therapeutics
|
11/06/2023 | 10-Q | 10-Q filing on 11/06/2023 | View Form |
|
HALO
Halozyme Therapeutics
|
08/08/2023 | 10-Q | 10-Q filing on 08/08/2023 | View Form |
|
HALO
Halozyme Therapeutics
|
05/09/2023 | 10-Q | 10-Q filing on 05/09/2023 | View Form |
|
HALO
Halozyme Therapeutics
|
11/08/2022 | 10-Q | 10-Q filing on 11/08/2022 | View Form |
|
HALO
Halozyme Therapeutics
|
08/09/2022 | 10-Q | 10-Q filing on 08/09/2022 | View Form |
|
HALO
Halozyme Therapeutics
|
05/10/2022 | 10-Q | 10-Q filing on 05/10/2022 | View Form |
|
HALO
Halozyme Therapeutics
|
11/02/2021 | 10-Q | 10-Q filing on 11/02/2021 | View Form |
|
HALO
Halozyme Therapeutics
|
08/09/2021 | 10-Q | 10-Q filing on 08/09/2021 | View Form |
|
HALO
Halozyme Therapeutics
|
05/10/2021 | 10-Q | 10-Q filing on 05/10/2021 | View Form |
|
HALO
Halozyme Therapeutics
|
11/02/2020 | 10-Q | 10-Q filing on 11/02/2020 | View Form |
|
HALO
Halozyme Therapeutics
|
08/10/2020 | 10-Q | 10-Q filing on 08/10/2020 | View Form |
|
HALO
Halozyme Therapeutics
|
05/11/2020 | 10-Q | 10-Q filing on 05/11/2020 | View Form |
|
HALO
Halozyme Therapeutics
|
02/24/2020 | 10-K | 10-K filing on 02/24/2020 | View Form |
|
HALO
Halozyme Therapeutics
|
11/12/2019 | 10-Q | 10-Q filing on 11/12/2019 | View Form |
|
HALO
Halozyme Therapeutics
|
08/06/2019 | 10-Q | 10-Q filing on 08/06/2019 | View Form |
|
HALO
Halozyme Therapeutics
|
05/07/2019 | 10-Q | 10-Q filing on 05/07/2019 | View Form |
|
HALO
Halozyme Therapeutics
|
02/21/2019 | 10-K | 10-K filing on 02/21/2019 | View Form |
|
HALO
Halozyme Therapeutics
|
11/06/2018 | 10-Q | 10-Q filing on 11/06/2018 | View Form |
|
HALO
Halozyme Therapeutics
|
08/07/2018 | 10-Q | 10-Q filing on 08/07/2018 | View Form |
|
HALO
Halozyme Therapeutics
|
05/10/2018 | 10-Q | 10-Q filing on 05/10/2018 | View Form |
|
HALO
Halozyme Therapeutics
|
02/20/2018 | 10-K | 10-K filing on 02/20/2018 | View Form |
|
HALO
Halozyme Therapeutics
|
11/07/2017 | 10-Q | 10-Q filing on 11/07/2017 | View Form |
|
HALO
Halozyme Therapeutics
|
08/08/2017 | 10-Q | 10-Q filing on 08/08/2017 | View Form |
|
HALO
Halozyme Therapeutics
|
05/09/2017 | 10-Q | 10-Q filing on 05/09/2017 | View Form |
|
HALO
Halozyme Therapeutics
|
02/28/2017 | 10-K | 10-K filing on 02/28/2017 | View Form |
|
HALO
Halozyme Therapeutics
|
11/07/2016 | 10-Q | 10-Q filing on 11/07/2016 | View Form |
|
HALO
Halozyme Therapeutics
|
08/09/2016 | 10-Q | 10-Q filing on 08/09/2016 | View Form |
|
HALO
Halozyme Therapeutics
|
05/09/2016 | 10-Q | 10-Q filing on 05/09/2016 | View Form |
|
HALO
Halozyme Therapeutics
|
02/29/2016 | 10-K | 10-K filing on 02/29/2016 | View Form |
|
HALO
Halozyme Therapeutics
|
11/09/2015 | 10-Q | 10-Q filing on 11/09/2015 | View Form |
|
HALO
Halozyme Therapeutics
|
08/11/2015 | 10-Q | 10-Q filing on 08/11/2015 | View Form |
|
HALO
Halozyme Therapeutics
|
08/10/2015 | 10-Q | 10-Q filing on 08/10/2015 | View Form |
|
HALO
Halozyme Therapeutics
|
05/11/2015 | 10-Q | 10-Q filing on 05/11/2015 | View Form |
|
HALO
Halozyme Therapeutics
|
03/02/2015 | 10-K | 10-K filing on 03/02/2015 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 3.65% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 4.9% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 4.4% over the past day.
